BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 126 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,505 | +48.4% | 212,698 | +47.6% | 0.02% | +66.7% |
| Q2 2023 | $1,014 | +95.8% | 144,062 | +131.5% | 0.01% | +50.0% |
| Q1 2023 | $518 | -99.8% | 62,223 | +161.4% | 0.01% | +100.0% |
| Q3 2022 | $299,000 | -83.5% | 23,803 | -81.1% | 0.00% | -72.7% |
| Q3 2021 | $1,812,000 | -3.3% | 126,125 | +6.4% | 0.01% | -35.3% |
| Q2 2021 | $1,874,000 | +362.7% | 118,550 | +197.6% | 0.02% | +325.0% |
| Q1 2021 | $405,000 | -82.0% | 39,830 | -86.8% | 0.00% | -91.1% |
| Q4 2020 | $2,247,000 | +916.7% | 301,682 | +289.6% | 0.04% | +350.0% |
| Q3 2019 | $221,000 | +35.6% | 77,424 | +605.6% | 0.01% | -87.0% |
| Q2 2015 | $163,000 | – | 10,973 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 1,186,726 | $4,076,000 | 2.45% |
| Sarissa Capital Management LP | 4,861,000 | $16,697,000 | 1.97% |
| Ghost Tree Capital, LLC | 1,950,000 | $6,698,000 | 1.94% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,525,857 | $8,676,000 | 1.14% |
| Eversept Partners, LP | 1,143,211 | $3,926,930 | 0.87% |
| DAFNA Capital Management LLC | 749,051 | $2,573,000 | 0.84% |
| KNOTT DAVID M | 397,361 | $1,365,000 | 0.80% |
| Parkman Healthcare Partners LLC | 800,740 | $2,751,000 | 0.73% |
| ACUTA CAPITAL PARTNERS, LLC | 660,000 | $2,267,000 | 0.62% |
| Formidable Asset Management, LLC | 578,200 | $1,949,000 | 0.57% |